BPS-MR-PAH-203

· Lung Biotechnology PBC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BPS-MR-PAH-203, covering 2019-09-16 to 2019-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients [Phase 2]